Get ready for the gap up ! When the China stock market reopens, this will be one stock that I expect to either gap up or moves strongly. It has recently breaks out from the bearish trend line.
Read more about the Company here .
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.24 CNY
395.26 M CNY
15.34 B CNY
1.20 B
About HARBIN PHARMACEUTICAL GROUP CO.,LTD.
Sector
Headquarters
Harbin
Founded
1991
Website
ISIN
CNE0000009T3
FIGI
BBG000BG02Z8
Harbin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, wholesale and retail of pharmaceutical products. Its products include calcium gluconate & zinc gluconate oral solution, amoxicillin capsules, shuanghuanglian oral liquid, alprostadil injection, pediatric acetaminophen yellow, namin granules, lacidipine tablets, cefotiam hydrochloride for injection, ibuprofen granules, xingai zhonggai calcium tablets. The company provides antibiotics, OTC, healthcare products, modern chinese medicines, biopharmaceuticals, animal vaccines and medicine circulations. Harbin Pharmaceutical Group was founded on December 28, 1991 and is headquartered in Harbin, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 600664 is 4.11 CNY — it has increased by 0.48% in the past 24 hours. Watch HARBIN PHARMACEUTICAL GROUP CO.,LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange HARBIN PHARMACEUTICAL GROUP CO.,LTD. stocks are traded under the ticker 600664.
600664 stock has risen by 3.49% compared to the previous week, the month change is a 16.57% rise, over the last year HARBIN PHARMACEUTICAL GROUP CO.,LTD. has showed a 13.85% increase.
600664 reached its all-time high on Nov 11, 2010 with the price of 16.33 CNY, and its all-time low was 2.33 CNY and was reached on Jul 18, 2005. View more price dynamics on 600664 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
600664 stock is 3.67% volatile and has beta coefficient of 1.23. Track HARBIN PHARMACEUTICAL GROUP CO.,LTD. stock price on the chart and check out the list of the most volatile stocks — is HARBIN PHARMACEUTICAL GROUP CO.,LTD. there?
Today HARBIN PHARMACEUTICAL GROUP CO.,LTD. has the market capitalization of 10.40 B, it has increased by 1.50% over the last week.
Yes, you can track HARBIN PHARMACEUTICAL GROUP CO.,LTD. financials in yearly and quarterly reports right on TradingView.
HARBIN PHARMACEUTICAL GROUP CO.,LTD. is going to release the next earnings report on Apr 9, 2025. Keep track of upcoming events with our Earnings Calendar.
600664 net income for the last quarter is 164.90 M CNY, while the quarter before that showed 166.64 M CNY of net income which accounts for −1.05% change. Track more HARBIN PHARMACEUTICAL GROUP CO.,LTD. financial stats to get the full picture.
HARBIN PHARMACEUTICAL GROUP CO.,LTD. dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 14, 2024, the company has 9.85 K employees. See our rating of the largest employees — is HARBIN PHARMACEUTICAL GROUP CO.,LTD. on this list?
Like other stocks, 600664 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HARBIN PHARMACEUTICAL GROUP CO.,LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HARBIN PHARMACEUTICAL GROUP CO.,LTD. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HARBIN PHARMACEUTICAL GROUP CO.,LTD. stock shows the buy signal. See more of HARBIN PHARMACEUTICAL GROUP CO.,LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.